Healthcare online HERO

Healthcare online Hero funded by #CEI PI Mariastefania Antica #Scientist #irb #Professor at SveučilišteJosipaJurjaStrossmayera Osijek

[Healthcare online HERO @Healthcareonli2]

Join us at the Annual Meeting of the Croatian Immunological Society with international participation
October 01–03, 2026
Venue: Hotel Tomislavov dom, Nature Park Medvednica, Zagreb Croatia
Application deadline: September 4, 2026

[Healthcare online HERO @Healthcareonli2]

The CorEuStem COST Action core group is meeting today in Milan at Human Technopole for evaluation and systainability for the Action

[International Myeloma Foundation @IMFmyeloma]

The IMF is working to answer the question: “Should we screen for MGUS?” This #NationalCancerResearchMonth, learn how we're working to stop MGUS from progressing to myeloma: https://t.co/WR0sCYp1oT #UnitedByCancerResearch #NCRM25 #IMFBSRI #MGUS
@sykristinsson

[Sean Morrison @SJMorrison_]

These are the people dismantling the National Institutes of Health, with no understanding of medical research. Nobody campaigned on eliminating US medical research. Americans assume the research is progressing and will be there if they get sick. They may be in for a surprise.

[Blood Cancer Journal @BloodCancerJnl]

Our Current Treatment Algorithms section provides an expert outline for treatment of hematologic malignancies.

See Myeloma algorithm by @VincentRK @myelomaMD @MayoCancerCare @MayoClinic #BCJ

Experts interested in being an author should contact editors. https://t.co/m66dLDMkUk

[Medthority @Medthority]

What qualifies as ‘good’ real-world evidence in VTE and AF clinical research? Find out with Dr Barnes and Dr Deitelzweig in the latest episode of ‘Thrombosis in conversation’

[International Myeloma Foundation @IMFmyeloma]

Although myeloma continues to be incurable, survival rates have increased each year since 2000. Help us share inspiring stories of hope! Thank you, Regeneron, for helping shine a light on myeloma during #MyelomaActionMonth. #MyelomaMilestone

[Organoid News @organoidscience]

Scientists from Peking University (@PKU1898) developed a microinjection-based method to quantify the growth time-dependent nonlinear elasticity of intestinal #organoids. 🧫

💡Learn more about their research: https://t.co/KrZOOl9xl1

[Roychoudhuri Lab @RoychoudhuriLab]

Thrilled to share new work led by @JieYang437 in the lab published today in @Nature. We find that Aspirin prevents metastasis by releasing T cells from immune suppression by platelet TXA2. @Cambridge_Uni @CRUKCamCentre https://t.co/dO2v0GWKAn

[UC Davis Health Medical Microbiology & Immunology @UCD_MMI]

Congratulations to Professor Dennis Hartigan-O’Connor for his $3.67 million @NIH grant! Our department is proud to be part of @UCDavisMed which is among the nation’s leading medical schools for National Institutes of Health (NIH) funding. https://t.co/TMGR1uAhYG

[International Myeloma Foundation @IMFmyeloma]

Although myeloma continues to be incurable, survival rates have increased each year since 2000. Help us share inspiring stories of hope! Thank you, @Regeneron, for helping shine a light on myeloma during #MyelomaActionMonth. #MyelomaMilestone

[Cell Therapy News @celltherapynews]

New in @sigtrans_sttt!

Scientists from Navy Medical University engineered mesothelin-specific CAR-NK cells that secrete neoleukin-2/15 to resist immunosuppressive polarization within the tumor microenvironment. 🧫

Know more: https://t.co/5L8njVfS8f

[Mesenchymal Cell News @MesenchymalCell]

This @SciReports study explored whether exosomes derived from adipose-derived #mesenchymal stem cells (AMSCs) had parental biological effects to AMSCs in the therapy of systemic sclerosis skin #fibrosis.

📖 Read about their findings: https://t.co/UCLWeS1qm3

[Organoid News @organoidscience]

Dr. @c_j_childs and colleagues at @TheSpenceLab generated an enhanced hPSC-derived human intestinal #organoid model that can simultaneously pattern epithelial, mesenchymal/stromal, neural, endothelial, and smooth-muscle populations.🧫

👉 https://t.co/234neM59GP

[Stem Cell Foundation @AusStemCell]

Blind No More? Revolutionary Stem Cell Therapy Restores Vision With 92% Success – Clinical trial finds experimental treatment for blinding cornea injuries is ‘feasible and safe’ in 14 patients, followed for 18 months.
Paper: https://t.co/L5Z5UEWgEA
https://t.co/2pwVfnOSfk

[Society of Hematologic Oncology (SOHO) @SocietyofHemOnc]

A modified quadruplet therapy is feasible for older, transplant-ineligible MM patients

https://t.co/2c3eUoYssL

[Healthcare online HERO @Healthcareonli2]

We are happy to announce that our HERO healthcare-online has been a great success, the logo and webpage made during the scary COVID time, educating the audience. Also, represents one of the first telemedicine platforms in Croatia and one of the first completely free.

[Science Careers @ScienceCareers]

Men psychology researchers can’t seem to remember their women colleagues

Men’s implicit bias may contribute to the gender gap in the field, this study highlights. #WomensHistoryMonth #WomenInSTEM https://t.co/t9qwGRfnDW

[Frontiers - Immunology @FrontImmunol]

New Research: Identification of DAP3 as candidate prognosis marker and potential therapeutic target for hepatocellular carcinoma https://t.co/HoLatBNknW #FrontiersIn #Immunology

[yEFIS @y_efis]

🚀 Calling All Immunologists! 🚀

@SiicaI is launching a new initiative on "Protocols"—a series of meetings to help immunologists master key technologies and pick up essential tips!

✍️ Register now:
https://t.co/Jizh5j4GGC

#Immunology #Protocols #SIICA #ScienceNetworking